Skip to main content
Top
Published in: International Urology and Nephrology 1/2019

01-01-2019 | Nephrology - Original Paper

The influence of chronic kidney disease on the duration of hospitalisation and transfusion rate after elective hip and knee arthroplasty

Authors: C. Kaiser, F. P. Tillmann, J. Löchter, S. Landgraeber, M. Jäger

Published in: International Urology and Nephrology | Issue 1/2019

Login to get access

Abstract

Purpose

Elective hip or knee replacement is an optimal, standardised orthopaedic surgical procedure. The influence of chronic kidney disease, defined as an estimated glomerular filtration rate (eGFR) of 15–45 ml/min/1.73 m2 body surface area (BSA) (KDIGO stage G3a-G4), on the duration of hospitalisation, perioperative decrease in haemoglobin (Hb) levels, and transfusion rates after orthopaedic procedures has not been fully clarified. Our study, therefore, aimed to evaluate the impact of chronic kidney disease on the previously mentioned variables.

Methods

We conducted a retrospective multicentre analysis involving two orthopaedic centres. Patients who underwent elective total hip and knee replacement between 2010 and 2015 were included. We used descriptive methods and multivariate linear and binary regression analyses for our statistical evaluations.

Results

We evaluated 3301 datasets (1120 men [33.9%], 2181 women [66.1%], 2043 [61.9%], and 1258 [38.1%]) elective total hip and knee replacements, respectively. The following variables were identified as risk factors for a prolonged hospital stay: patient age, admission Hb and potassium levels, perioperative Hb level decrease, year of surgery, blood transfusion, and a preoperative eGFR of 15–45 ml/min/m2 BSA. Patients with an eGFR of > 45 ml/min/m2 BSA were discharged within 11.7 ± 3.0 days, while patients with an eGFR of 15–45 ml/min/1.73 m2 BSA remained inpatient for 13.5 ± 5.0 days (p < 0.001). Identified risk factors for postoperative blood transfusions included age, initial Hb level, perioperative Hb decrease, prosthetic hip replacement, and the presence of allergic diathesis. Blood transfusions were performed in 7.5% of patients with an eGFR of > 45 ml/min/m2 BSA compared to 24.1% of patients with an eGFR of 15–45 ml/min/1.73 m2 BSA (p < 0.001). An eGFR level of 15–45 ml/min/m2 BSA was identified as a risk factor for a postoperative decrease in Hb levels.

Conclusion

Chronic kidney disease, defined as an eGFR level of 15–45 ml/min/1.73 m2 BSA, was a risk factor for a prolonged hospital stay after elective hip and knee arthroplasty. Further studies are necessary to better define the effect of reduced kidney function on relevant clinical and socioeconomic outcome parameters.
Literature
1.
go back to reference Learmonth ID, Young C, Rorabeck C (2007) The operation of the century: total hip replacement. Lancet 370:1508–1519CrossRefPubMed Learmonth ID, Young C, Rorabeck C (2007) The operation of the century: total hip replacement. Lancet 370:1508–1519CrossRefPubMed
2.
go back to reference Fry DE, Pine M, Nedza SM, Locke DG, Reband AM, Pine G (2017) Risk-adjusted hospital outcomes in medicare total joint replacement surgical procedures. J Bone Joint Surg Am 99:10–18CrossRefPubMed Fry DE, Pine M, Nedza SM, Locke DG, Reband AM, Pine G (2017) Risk-adjusted hospital outcomes in medicare total joint replacement surgical procedures. J Bone Joint Surg Am 99:10–18CrossRefPubMed
4.
go back to reference Meding JB, Klay M, Healy A, Ritter MA, Keating EM, Berend ME (2007) The prescreening history and physical in elective total joint arthroplasty. J Arthroplast 22:21–23CrossRef Meding JB, Klay M, Healy A, Ritter MA, Keating EM, Berend ME (2007) The prescreening history and physical in elective total joint arthroplasty. J Arthroplast 22:21–23CrossRef
5.
go back to reference Scott JE, Mathias JL, Kneebone AC, Krishnan J (2017) Postoperative cognitive dysfunction and its relationship to cognitive reserve in elderly total joint replacement patients. J Clin Exp Neuropsychol 39:459–472CrossRefPubMed Scott JE, Mathias JL, Kneebone AC, Krishnan J (2017) Postoperative cognitive dysfunction and its relationship to cognitive reserve in elderly total joint replacement patients. J Clin Exp Neuropsychol 39:459–472CrossRefPubMed
6.
go back to reference Stevens PE, Lamb EJ, Levin A (2015) Integrating guidelines, CKD, multimorbidity, and older adults. Am J Kidney Dis 65:494–501CrossRefPubMed Stevens PE, Lamb EJ, Levin A (2015) Integrating guidelines, CKD, multimorbidity, and older adults. Am J Kidney Dis 65:494–501CrossRefPubMed
7.
go back to reference Torres RV, Elias MF, Seliger S, Davey A, Robbins MA (2017) Risk for cognitive impairment across 22 measures of cognitive ability in early stage chronic kidney disease. Nephrol Dial Transplant 32:299–306CrossRefPubMed Torres RV, Elias MF, Seliger S, Davey A, Robbins MA (2017) Risk for cognitive impairment across 22 measures of cognitive ability in early stage chronic kidney disease. Nephrol Dial Transplant 32:299–306CrossRefPubMed
8.
go back to reference Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutierrez OM et al (2017) KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of the chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 70:737–751CrossRefPubMed Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutierrez OM et al (2017) KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of the chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 70:737–751CrossRefPubMed
9.
go back to reference Babayev R, Nickolas TL (2015) Bone disorders in chronic kidney disease: an update in diagnosis and management. Semin Dial 28:645–653CrossRefPubMed Babayev R, Nickolas TL (2015) Bone disorders in chronic kidney disease: an update in diagnosis and management. Semin Dial 28:645–653CrossRefPubMed
10.
go back to reference Molino D, De Lucia D, Gaspare De Santo N (2006) Coagulation disorders in uremia. Semin Nephrol 26:46–51CrossRefPubMed Molino D, De Lucia D, Gaspare De Santo N (2006) Coagulation disorders in uremia. Semin Nephrol 26:46–51CrossRefPubMed
11.
go back to reference Hsu CY, McCulloch CE, Curhan GC (2002) Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13:504–510CrossRefPubMed Hsu CY, McCulloch CE, Curhan GC (2002) Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13:504–510CrossRefPubMed
12.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AR 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AR 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
13.
go back to reference Schwartz FH, Lange J (2017) Factors that affect outcome following total joint arthroplasty: a review of the recent literature. Curr Rev Musculoskelet Med 10:346–355CrossRefPubMedPubMedCentral Schwartz FH, Lange J (2017) Factors that affect outcome following total joint arthroplasty: a review of the recent literature. Curr Rev Musculoskelet Med 10:346–355CrossRefPubMedPubMedCentral
14.
go back to reference Abbott KC, Bucci JR, Agodoa LY (2003) Total hip arthroplasty in chronic dialysis patients in the United States. J Nephrol 16:34–39PubMed Abbott KC, Bucci JR, Agodoa LY (2003) Total hip arthroplasty in chronic dialysis patients in the United States. J Nephrol 16:34–39PubMed
15.
go back to reference Bucci JR, Oglesby RJ, Agodoa LY, Abbott KC (2002) Hospitalizations for total hip arthroplasty after renal transplantation in the United States. Am J Transplant 2:999–1004CrossRefPubMed Bucci JR, Oglesby RJ, Agodoa LY, Abbott KC (2002) Hospitalizations for total hip arthroplasty after renal transplantation in the United States. Am J Transplant 2:999–1004CrossRefPubMed
16.
go back to reference Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG (2011) Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg 112:1375–1381CrossRefPubMed Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG (2011) Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg 112:1375–1381CrossRefPubMed
17.
go back to reference Deegan BF, Richard RD, Bowen TR, Perkins RM, Graham JH, Foltzer MA (2014) Impact of chronic kidney disease stage on lower-extremity arthroplasty. Orthopedics 37:e613–e618CrossRefPubMed Deegan BF, Richard RD, Bowen TR, Perkins RM, Graham JH, Foltzer MA (2014) Impact of chronic kidney disease stage on lower-extremity arthroplasty. Orthopedics 37:e613–e618CrossRefPubMed
18.
go back to reference Miric A, Inacio MC, Namba RS (2014) The effect of chronic kidney disease on total hip arthroplasty. J Arthroplast 29:1225–1230CrossRef Miric A, Inacio MC, Namba RS (2014) The effect of chronic kidney disease on total hip arthroplasty. J Arthroplast 29:1225–1230CrossRef
19.
go back to reference Warth LC, Pugely AJ, Martin CT, Gao Y, Callaghan JJ (2015) Total joint arthroplasty in patients with chronic renal disease: Is it worth the risk? J Arthroplast 30:51–54CrossRef Warth LC, Pugely AJ, Martin CT, Gao Y, Callaghan JJ (2015) Total joint arthroplasty in patients with chronic renal disease: Is it worth the risk? J Arthroplast 30:51–54CrossRef
20.
go back to reference Cavanaugh PK, Chen AF, Rasouli MR, Post ZD, Orozco FR, Ong AC (2016) Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty: a comparison between dialysis and renal transplant patients. J Arthroplast 31:465–472CrossRef Cavanaugh PK, Chen AF, Rasouli MR, Post ZD, Orozco FR, Ong AC (2016) Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty: a comparison between dialysis and renal transplant patients. J Arthroplast 31:465–472CrossRef
21.
go back to reference Graves A, Yates P, Hofmann AO, Farmer S, Ferrari P (2014) Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty. Nephrology 19:404–409CrossRefPubMed Graves A, Yates P, Hofmann AO, Farmer S, Ferrari P (2014) Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty. Nephrology 19:404–409CrossRefPubMed
22.
go back to reference Augustin ID, Yeoh TY, Sprung J, Berry DJ, Schroeder DR, Weingarten TN (2013) Association between chronic kidney disease and blood transfusions for knee and hip arthroplasty surgery. J Arthroplast 28:928–931CrossRef Augustin ID, Yeoh TY, Sprung J, Berry DJ, Schroeder DR, Weingarten TN (2013) Association between chronic kidney disease and blood transfusions for knee and hip arthroplasty surgery. J Arthroplast 28:928–931CrossRef
23.
go back to reference Kuo FC, Lin PC, Lu YD, Lee MS, Wang JW (2017) Chronic kidney disease is an independent risk factor for transfusion, cardiovascular complication, and thirty-day readmission in minimally invasive total knee arthroplasty. J Arthroplast 32:1630–1634CrossRef Kuo FC, Lin PC, Lu YD, Lee MS, Wang JW (2017) Chronic kidney disease is an independent risk factor for transfusion, cardiovascular complication, and thirty-day readmission in minimally invasive total knee arthroplasty. J Arthroplast 32:1630–1634CrossRef
24.
go back to reference Adogwa O, Elsamadicy AA, Sergesketter A, Oyeyemi D, Galan D, Vuong VD et al (2017) The impact of chronic kidney disease on post-operative outcomes in patients undergoing lumbar decompression and fusion. World Neurosurg 110:e266–e270CrossRefPubMed Adogwa O, Elsamadicy AA, Sergesketter A, Oyeyemi D, Galan D, Vuong VD et al (2017) The impact of chronic kidney disease on post-operative outcomes in patients undergoing lumbar decompression and fusion. World Neurosurg 110:e266–e270CrossRefPubMed
Metadata
Title
The influence of chronic kidney disease on the duration of hospitalisation and transfusion rate after elective hip and knee arthroplasty
Authors
C. Kaiser
F. P. Tillmann
J. Löchter
S. Landgraeber
M. Jäger
Publication date
01-01-2019
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-2008-5

Other articles of this Issue 1/2019

International Urology and Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.